Publications by authors named "Alan Pollack"

Claim this Profile
R
Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence.
Anson T Ku, Uma Shankavaram, Shana Y Trostel, Hong Zhang, Sumeyra Kartal, Alan Pollack

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials.
Todd M Morgan, Yi Ren, Siyi Tang, Wouter Zwerink, Emmalyn Chen, Alan Pollack

Eur Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Genomic Classifiers in Biopsy Cores With Grade Group 1 Cancer Predict Higher-Grade Disease Elsewhere in the Prostate? Results From the Prospective Miami Active Surveillance Trial.
Pedro F S Freitas, Archan Khandekar, Joao G Porto, Hui Yu, Adam D Williams, Alan Pollack

J Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Pedro F S Freitas, Archan Khandekar, Joao G Porto, Hui Yu, Adam D Williams, Alan Pollack

J Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of Habitat Risk Score in Radiation Therapy for Prostate Cancer.
Evangelia I Zacharaki, Adrian L Breto, Ahmad Algohary, Veronica Wallaengen, Yiwei Jia, Alan Pollack

Int J Radiat Oncol Biol Phys· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data.
Sarah Burdett, David J Fisher, Jayne F Tierney, Adrian D Cook, Daniel E Spratt, Alan Pollack

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial.
Ryan M Phillips, James A Proudfoot, Elai Davicioni, Yang Liu, Daniel E Spratt, Alan Pollack

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-Induced Nephrotoxicity: Role of Sphingomyelin Phosphodiesterase Acid-like 3b.
Anis Ahmad, Shamroop Kumar Mallela, Saba Ansari, Mohammed Alnukhali, Misha Ali, Alan Pollack

Int J Radiat Oncol Biol Phys· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression.
Isabella M Kimbel, Veronica Wallaengen, Evangelia I Zacharaki, Adrian L Breto, Ahmad Algohary, Alan Pollack

Acad Radiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score.
Helen Y Hougen, Isildinha M Reis, Sunwoo Han, Nachiketh Soodana Prakash, Jamie Thomas, Alan Pollack

Prostate Cancer Prostatic Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST Trial.
Tarek Ajami, Hui Yu, Joao G Porto, Nachiketh Soodana Prakash, Adam Williams, Alan Pollack

Eur Urol Focus· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.
Krishnan R Patel, Paul L Nguyen, James A Proudfoot, Yang Liu, Alan Dal Pra, Alan Pollack

Eur Urol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer.
Mohammed Alnukhali, Omar Altabbakh, Ammad Ahmad Farooqi, Alan Pollack, Sylvia Daunert

Curr Med Chem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712.
Zaker Rana, Sophia C Kamran, Amol C Shetty, Philip Sutera, Yang Song, Alan Pollack

Eur Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated framework for quantitative T2-weighted MRI analysis following prostate cancer radiotherapy.
Evangelia I Zacharaki, Adrian L Breto, Ahmad Algohary, Veronica Wallaengen, Sandra M Gaston, Alan Pollack

Phys Imaging Radiat Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Smart Water Bottle and Companion App (HidrateSpark 3) to Improve Bladder-Filling Compliance in Patients With Prostate Cancer Receiving Radiotherapy: Nonrandomized Trial of Feasibility and Acceptability.
William Jin, Christopher Montoya, Benjamin James Rich, Crystal Seldon Taswell, Miguel Noy, Alan Pollack

JMIR Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy.
Subham Guin, Akash Ashokan, Alan Pollack, Shanta Dhar

ACS Pharmacol Transl Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancers.
Oleksandr N Kryvenko, Jonathan I Epstein, Ali Merhe, Oleksii A Iakymenko, Ricardo De Almeida E Silva Junior, Alan Pollack

Am J Clin Pathol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen deprivation therapy combined with postoperative radiotherapy for prostate cancer management.
Alan Pollack, Alan Dal Pra

Lancet· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique.
Ahmad Algohary, Evangelia I Zacharaki, Adrian L Breto, Mohammad Alhusseini, Veronica Wallaengen, Alan Pollack

NMR Biomed· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation nephropathy: Mechanisms of injury and recovery in a murine model.
Anis Ahmad, Junwei Shi, Saba Ansari, Sandra Merscher, Alan Pollack

Radiother Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI.
Radka Stoyanova, Olmo Zavala-Romero, Deukwoo Kwon, Adrian L Breto, Isaac R Xu, Alan Pollack

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody-Gaussia Luciferase Fusion Protein.
Jessica Hersh, Yu-Ping Yang, Evan Roberts, Daniel Bilbao, Wensi Tao, Alan Pollack

Pharmaceutics· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence.
Anson T Ku, Uma Shankavaram, Shana Y Trostel, Hong Zhang, Houssein A Sater, Alan Pollack

medRxiv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classifying Malignancy in Prostate Glandular Structures from Biopsy Scans with Deep Learning.
Ryan Fogarty, Dmitry Goldgof, Lawrence Hall, Alex Lopez, Joseph Johnson, Alan Pollack

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis